Three-year Fronzaroli fellowships 2026-2027

2 three-year fellowships named Fronzaroli (called in the application form Fronzaroli X where X is a sequential number linked to the project) are available, intended for candidates who choose one of the projects accredited for this type of fellowship.

The 2 Fronzaroli fellowships will be awarded to the first 2 eligible candidates in the final rankings who selected them when submitting their application for admission to the competition.

Please note that candidates intending to apply for a Fronzaroli fellowship must select the project of interest—among those accredited for this type of funding—directly from the list available in the online application form for admission.

The project will be assigned based on the candidate’s position in the ranking and the order of preferences indicated.

If both winners were to choose the same project, it will be assigned to the candidate with the highest-ranking score. The second winner will have to indicate another project among those remaining available for this type of fellowship (Fronzaroli).

It is hereby specified that the projects accredited under the two Fronzaroli scholarships may also be included among the preferences for free projects, irrespective of the allocation of the related scholarship.

It is hereby specified that the projects accredited under the two Fronzaroli scholarships may also be included among the preferences for free projects, irrespective of the allocation of the related scholarship.

The list of accredited projects and the corresponding affiliated curricula can be found below.

Two three-year Fronzaroli Fellowships

Fronzaroli1: BOLINO ALESSANDRA

Unit: Human Inherited Neuropathies Unit

Curriculum in Neuroscience and Experimental Neurology

AAV-mediated gene therapy to treat inherited neuropathies with aberrant myelin

Fronzaroli2: BRAGONZI ALESSANDRA

Unit: Infection and Cystic Fibrosis Unit

Curriculum in Basic and Applied Immunology and Oncology

Gut-Lung axis in Cystic Fibrosis: pathophysiological basis for diagnostic and therapeutic approaches

Fronzaroli3: CASSINA LAURA

Unit: Cystic Kidney Disorders

Curriculum in Cellular and Molecular Biology

Recessive Polycystic Kidney Disease: mechanistic insights on mitochondrial dysfunction

Fronzaroli4: COLASANTE GAIA

Unit: Stem Cell and Neurogenesis

Curriculum in Gene and Cell Therapy

Treating Dravet syndrome caused by dominant negative mutations

Fronzaroli5: COLNAGHI LUCA

Unit: Protein signaling in brain physiology and pathology, Neuroscience Division

Curriculum in Neuroscience and Experimental Neurology

Protein quality control in NEDAMSS, a rare neurodevelopmental disorder

Fronzaroli6: CRIPPA STEFANIA

Unit: San Raffaele Telethon Institute For Gene Therapy, Pathogenesis and Therapy of LSDS with Skeletal Involvement Unit

Curriculum in Gene and Cell Therapy

Modelling skeletal defects in MPSIVA to enhance HSPC-GT therapeutic efficacy

Fronzaroli7: GABELLINI DAVIDE

Unit: Gene Expression Regulation

Curriculum in Biologia Cellulare e Molecolare

Understanding and treating muscle inflammation in FSHD muscular dystrophy

Fronzaroli8: MUSCO GIOVANNA

Unit: Biomolecular NMR

Curriculum in Cellular and Molecular Biology

Rational design of drug-like peptides blocking aberrant DUX4 in FSHD

Fronzaroli9: NAI ANTONELLA

Unit: Regulation of Iron Metabolism Unit

Curriculum in Cellular and Molecular Biology

Identification of new strategies for in vivo targeting of erythroid Tfr2 in β-thalassemia

Fronzaroli10: PREVITALI STEFANO CARLO

Unit: Neuromuscular Repair Unit

Curriculum in Neuroscience and Experimental Neurology

An Integrated Genomic, Phenotypic, and Functional Pipeline for the Molecular Diagnosis of Unresolved Inherited Neuromuscular Disorders

Fronzaroli11: RAMPOLDI LUCA

Unit: Neuromuscular Repair Unit

Curriculum in Cellular and Molecular Biology

Molecular mechanisms of pathogenesis in Autosomal Dominant Tubulointerstitial Kidney Disease due to renin mutations

Fronzaroli12: SESSA ALESSANDRO

Unit: Neuroepigenetics

Curriculum in Neuroscience and Experimental Neurology

Gene Therapy approaches for SETBP1 Haploinsufficiency Disorder

Fronzaroli13: VENEREAU EMILIE

Unit: Tissue Regeneration & Homeostasis Unit

Curriculum in Cellular and Molecular Biology

Preclinical Evaluation of a Designer HMGB1 as a Drug Candidate for Duchenne Muscular Dystrophy